A new chromogenic assay (HemosIL ThromboPath) is sensitive to major prothrombotic risk factors affecting the protein C pathway. Results a multicenter study

被引：0

作者：

Toulon, Pierre A. ^{[1
]}

Smirnov, Mikhail ^{[2
]}

Triscott, Mark ^{[2
]}

Tripodi, Armando ^{[3
]}

机构：

[1] Univ Nice, Nice, France

[2] R&D Instrumentat Lab, Orangeburg, NY USA

[3] Angelo Bianchi Bonomi Ctr, Milan, Italy

来源：

BLOOD | 2007年 / 110卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1626

引用

页码：485A / 485A

页数：1

共 8 条

[1] A new chromogenic assay (HemosIL ThromboPath) is sensitive to major prothrombotic risk factors affecting the protein C pathway. Results of a multicenter study
Toulon, Pierre
Smirnov, Mikhail
Triscott, Mark
Safa, Omid
Biguzzi, Eugenia
Bouziane, Kader
Tripodi, Armando
THROMBOSIS RESEARCH, 2009, 124 (01) : 137 - 143
[2] Performance of a new global chromogenic assay (HemosIL ThromboPath) for Protein C pathway: results of a multicenter study
Toulon, P.
Smirnov, M.
Triscott, M.
Tripodi, A.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 : 106 - 106
[3] Performance of a New Global Chromogenic Assay for Protein C Pathway (HemosIL ThromboPath) in the Diagnosis of Lupus Anticoagulant and Antiphospholipid Antibodies
Toulon, Pierre A.
Martin-Toutain, Isabelle
Piette, Jean-Charles
Diemert, Marie-Claude
Ankri, Annick
BLOOD, 2008, 112 (11) : 795 - 795
[4] Screening of Protein C Pathway Abnormalities in 597 Unselected Consecutive Patients with a History of Thrombosis Using a New Chromogenic Assay (HemosIL ThromboPath).
Toulon, Pierre A.
Martin-Toutain, Isabelle
Ankri, Annick
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (11) : E220 - E221
[5] Performance of the HemosIL Thrombopath assay in the screening for protein C pathway abnormalities. preliminary results in 352 unselected patients with a history of thrombosis
Toulon, P. A.
Toutain, Martin, I
Ankri, A.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 738 - 738
[6] Economic Impact of a Screening Strategy for Protein C Pathway Abnormalities Based on a New Global Chromogenic Assay (HemosIL ThromboPath) as a First Step Screening Assay In a Series of 597 Unselected Consecutive Patients.
Toulon, Pierre A.
Martin-Toutain, Isabelle
Ankri, Annick
BLOOD, 2010, 116 (21) : 1564 - 1564
[7] ProC Global, a new screening assay to assess the functionality of the protein C protein S anticoagulant pathway: Results of a multicenter trial in patients with thrombophilia
Toulon, P
Wagner, C
BLOOD, 1997, 90 (10) : 664 - 664
[8] The result of the ProC Global assay is a risk factor for venous thromboembolism independent of its sensitivity for protein C pathway abnormalities. Results of a case-control study.
Toulon, PA
Perez, P
BLOOD, 2001, 98 (11) : 42A - 43A

← 1 →